Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | March 2012

Suprarenal Fixation Is Required for EVAR

The advantages afforded with suprarenal fixation when treating abdominal aortic aneurysms.

By Benjamin M. Jackson, MD, and Ronald M. Fairman, MD

evt | Article | August 2009

Operative Approaches to Renal Artery Aneurysms

An overview of the surgical and endovascular options for this rare but treatable condition.

By Benjamin M. Jackson, MD, and Edward Y. Woo, MD

evt | Article | August 2008

Hybrid Procedures in the Treatment of Carotid Stenosis

A feasible technique applied to complex carotid plaque and anatomy.

By Elena Y. Rakhlin, MD; Ronald M. Fairman, MD; Jeffrey P. Carpenter, MD; Grace J. Wang, MD; Benjamin M. Jackson, MD; and Edward Y. Woo, MD

evt | News | August 7, 2011

Gender Analysis of Medtronic's VALOR Trial Results Published

August 8, 2011—In the Journal of Vascular Surgery, Benjamin M. Jackson, MD, et al published findings from a study that evaluated the differences between male and female patients undergoing thoracic endovascular aneurysm repair (TEVAR) in the pivotal VALOR (The Evaluation of the Medtronic Vascular Talent Thoracic Stent Graft System [Medtronic, Inc. Minneapolis, MN] for the Treatment of Thoracic Aortic Aneurysms) trial (2011;54:358–363). VALOR was a prospective, nonrandomized, multicenter, pivotal trial conducted in the United States. Patients were enrolled between December 2003 and June 2005. Follow-up was conducted at 30 days and 1 year.

Advertisement

Advertisement

evt | Article | March 2012

Chief Medical Editor's Page

More EVAR Options, But Also More Questions

By Ronald M. Fairman, MD, and Edward Y. Woo, MD

evt | Article | August 2009

Continued Study, Debate, and Collaboration

By Andrew Holden, MBChB, FRANZCR, and Robert Bersin, MD - Guest Chief Medical Editors

evt | Article | August 2008

Venous Update

By Barry T. Katzen, MD, Chief Medical Editor

evt | Article | August 2017

Real-World Decision Making

By John A. Kaufman, MD

evt | Article | August 2017

Acute Type A Aortic Dissection

Moderator: Ali Azizzadeh, MD, FACS
Panel: Benjamin Jackson, MD, FACS; Joseph Bavaria, MD, FACS; Kristofer M. Charlton-Ouw, MD, FACS; Anthony L. Estrera, MD, FACS; Michael Fischbein, MD, PhD; Michael D. Dake, MD; and Jason T. Lee, MD


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button